Department of Medical Biophysics, University of Toronto, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario M5G 2M9, Canada.
J Biol Chem. 2013 May 10;288(19):13563-74. doi: 10.1074/jbc.M113.460436. Epub 2013 Mar 27.
The enzyme “GluI” is key to the synthesis of critical glycoproteins in the cell.
We have determined the structure of GluI, and modeled binding with its unique sugar substrate.
The specificity of this interaction derives from a unique conformation of the substrate.
Understanding the mechanism of the enzyme is of basic importance and relevant to potential development of antiviral inhibitors. Processing α-glucosidase I (GluI) is a key member of the eukaryotic N-glycosylation processing pathway, selectively catalyzing the first glycoprotein trimming step in the endoplasmic reticulum. Inhibition of GluI activity impacts the infectivity of enveloped viruses; however, despite interest in this protein from a structural, enzymatic, and therapeutic standpoint, little is known about its structure and enzymatic mechanism in catalysis of the unique glycan substrate Glc3Man9GlcNAc2. The first structural model of eukaryotic GluI is here presented at 2-Å resolution. Two catalytic residues are proposed, mutations of which result in catalytically inactive, properly folded protein. Using Autodocking methods with the known substrate and inhibitors as ligands, including a novel inhibitor characterized in this work, the active site of GluI was mapped. From these results, a model of substrate binding has been formulated, which is most likely conserved in mammalian GluI.
酶“GluI”是细胞中关键糖蛋白合成的关键。
我们已经确定了 GluI 的结构,并对其与独特糖底物的结合进行了建模。
这种相互作用的特异性源于底物的独特构象。
了解酶的机制具有基本重要性,并且与潜在的抗病毒抑制剂的开发相关。
处理α-葡萄糖苷酶 I(GluI)是真核 N-糖基化加工途径的关键成员,选择性地催化内质网中第一个糖蛋白修剪步骤。GluI 活性的抑制会影响包膜病毒的感染力;然而,尽管从结构、酶学和治疗角度对该蛋白很感兴趣,但对于其在催化独特聚糖底物 Glc3Man9GlcNAc2 中的结构和酶促机制知之甚少。这里以 2-Å 的分辨率呈现了真核 GluI 的第一个结构模型。提出了两个催化残基,突变这两个残基会导致催化失活但正确折叠的蛋白质。使用自动对接方法,以已知的底物和抑制剂作为配体,包括本工作中表征的一种新型抑制剂,对 GluI 的活性位点进行了映射。根据这些结果,制定了一个可能在哺乳动物 GluI 中保守的底物结合模型。